Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

Stopped Strategic decision to discontinue the study based on adjusted clinical development plan. This decision is not based on any safety concerns.

Conditions

• Asthma

Interventions

• DRUG: Zavegepant
• DRUG: Placebo

Sponsor

Pfizer